Stay updated on Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The new screenshot shows a very similar Record History page with a slightly adjusted layout and header labels, but no new study data or status changes are visible. The update appears to be a minor UI/visual change rather than a substantive modification to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-02T00:36:21.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    Updated operating status notice and a new release version (v3.2.0) replacing the old v3.1.0.
    Difference
    12%
    Check dated 2025-10-04T11:33:45.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-27T07:34:04.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the Back to Top link was removed. No other core content changes were detected.
    Difference
    0.7%
    Check dated 2025-09-13T01:38:48.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.7%
    Check dated 2025-09-05T19:34:30.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location details, while several location-related terms have been removed.
    Difference
    17%
    Check dated 2025-08-29T16:07:54.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.